The role of the corpus callosum in seizure spread: MRI lesion mapping in oligodendrogliomas

Epilepsy Research

Volumn 109, Issue 1, 2015, Pages 126-133

  Wieshmann, U C ^a   Milinis, K ^a   Paniker, J ^a   Das, K ^a   Jenkinson, M D ^a   Brodbelt, A ^a   Crooks, D ^a   Keller, S S ^a,b  

^a THE WALTON CENTRE NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Epilepsy; Genu of the corpus callosum; Lesion mapping; Oligodendroglioma; Secondary generalization

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN; BRAIN MAPPING; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; CORPUS STRIATUM; DISEASE ASSOCIATION; FEMALE; FOCAL EPILEPSY; HUMAN; MALE; MIDDLE AGED; NERVOUS SYSTEM PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OLIGODENDROGLIOMA; REGION OF INTEREST; THALAMUS; TONIC CLONIC SEIZURE; TUMOR LOCALIZATION; BRAIN TUMOR; IMAGE PROCESSING; PATHOLOGY; SEIZURE;

ADULT; BRAIN NEOPLASMS; CORPUS CALLOSUM; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OLIGODENDROGLIOMA; SEIZURES;

EID: 84922664427     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2014.10.023     Document Type: Article

References (25)

1. Andersen S.M., Rapcsak S.Z., Beeson P.M. Cost function masking during normalization of brains with focal lesions: still a necessity?. NeuroImage 2010, 53:78-84.
2. Bailey P., Cushing H. A Classification of the Tumors of the Glioma Group on a Histogenetic Basis with a Correlated Study of Prognosis 1926, Lippincott, Philadelphia, PA.
3. Brett M., Leff A.P., Rorden C., Ashburner J. Spatial normalization of brain images with focal lesions using cost function masking. NeuroImage 2001, 14:486-500.
4. Chang E.F., Potts M.B., Keles G.E., Lamborn K.R., Chang S.M., Barbaro N.M., Berger M.S. Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J. Neurosurg. 2008, 108:227-235.
5. Crinion J., Ashburner J., Leff A., Brett M., Price C., Friston K. Spatial normalization of lesioned brains: performance evaluation and impact on fMRI analyses. NeuroImage 2007, 37:866-875.
6. Dodson E. Definitions and classification of epilepsy. The Treatment of Epilepsy 2004, 3-20. Blackwell Science Ltd, Oxford. second ed. S. Shorvon, E. Perucca, D. Fish, E. Dodson (Eds.).
7. Giannini C., Scheithauer B.W., Weaver A.L., Burger P.C., Kros J.M., Mork S., Graeber M.B., Bauserman S., Buckner J.C., Burton J., Riepe R., Tazelaar H.D., Nascimento A.G., Crotty T., Keeney G.L., Pernicone P., Altermatt H. Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading. J. Neuropathol. Exp. Neurol. 2001, 60:248-262.
8. Hua K., Zhang J., Wakana S., Jiang H., Li X., Reich D.S., Calabresi P.A., Pekar J.J., van Zijl P.C., Mori S. Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. NeuroImage 2008, 39:336-347.
9. Huang L., You G., Jiang T., Li G., Li S., Wang Z. Correlation between tumor-related seizures and molecular genetic profile in 103 Chinese patients with low-grade gliomas: a preliminary study. J. Neurol. Sci. 2011, 302:63-67.
10. Ketz E. Brain tumors and epilepsy. Handbook of Clinical Neurology 1974, vol. 16:254-269. North-Holland Publishing Company, Amsterdam.
11. Karnath H.O., Fruhmann Berger M., Kuker W., Rorden C. The anatomy of spatial neglect based on voxelwise statistical analysis: a study of 140 patients. Cereb. Cortex 2004, 14:1164-1172.
12. Marchina S., Zhu L.L., Norton A., Zipse L., Wan C.Y., Schlaug G. Impairment of speech production predicted by lesion load of the left arcuate fasciculus. Stroke 2011, 42:2251-2256. A Journal of Cerebral Circulation.
13. Matthews L., Marasco R., Jenkinson M., Kuker W., Luppe S., Leite M.I., Giorgio A., De Stefano N., Robertson N., Johansen-Berg H., Evangelou N., Palace J. Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology 2013, 80:1330-1337.
14. Mazziotta J., Toga A., Evans A., Fox P., Lancaster J., Zilles K., Woods R., Paus T., Simpson G., Pike B., Holmes C., Collins L., Thompson P., MacDonald D., Iacoboni M., Schormann T., Amunts K., Palomero-Gallagher N., Geyer S., Parsons L., Narr K., Kabani N., Le Goualher G., Boomsma D., Cannon T., Kawashima R., Mazoyer B. A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos. Trans. R. Soc. London, B: Biol. Sci. 2001, 356:1293-1322.
15. Morris H.H., Estes M.L., Gilmore R., Van Ness P.C., Barnett G.H., Turnbull J. Chronic intractable epilepsy as the only symptom of primary brain tumor. Epilepsia 1993, 34:1038-1043.
16. Rinne P., Hassan M., Goniotakis D., Chohan K., Sharma P., Langdon D., Soto D., Bentley P. Triple dissociation of attention networks in stroke according to lesion location. Neurology 2013, 81:812-820.
17. Rorden C., Karnath H.O. Using human brain lesions to infer function: a relic from a past era in the fMRI age?. Nat. Rev. Neurosci. 2004, 5:813-819.
18. Rorden C., Karnath H.O., Bonilha L. Improving lesion-symptom mapping. J. Cogn. Neurosci. 2007, 19:1081-1088.
19. Sanjuan A., Price C.J., Mancini L., Josse G., Grogan A., Yamamoto A.K., Geva S., Leff A.P., Yousry T.A., Seghier M.L. Automated identification of brain tumors from single MR images based on segmentation with refined patient-specific priors. Front. Neurosci. 2013, 7:241.
20. Seghier M.L., Ramlackhansingh A., Crinion J., Leff A.P., Price C.J. Lesion identification using unified segmentation-normalisation models and fuzzy clustering. NeuroImage 2008, 41:1253-1266.
21. Tanriverdi T., Olivier A., Poulin N., Andermann F., Dubeau F. Long-term seizure outcome after corpus callosotomy: a retrospective analysis of 95 patients. J. Neurosurg. 2009, 110:332-342.
22. Tukel K., Jasper H. The electroencephalogram in parasagittal lesions. Electroencephalogr. Clin. Neurophysiol. 1952, 4:481-494.
23. Van Wagenen W.P., Herren R.Y. Surgical division of commisural pathways in the corpus callosum; relation to spread of epileptic attack. Arch. Neurol. Psychiatry 1940, 44:740-759.
24. Walker C., Du Plessis D.G., Joyce K.A., Fildes D., Gee A., Haylock B., Husband D., Smith T., Broome J., Warnke P.C. Molecular pathology and clinical characteristics of oligodendroglial neoplasms. Ann. Neurol. 2005, 57:855-865.
25. Whittle I.R., Beaumont A. Seizures in patients with supratentorial oligodendroglial tumors clinicopathological features and management considerations. Acta. Neurochir. (Wien) 1995, 135:19-24.